ARTLX | VIVAX | ARTLX / VIVAX | |
Total Expense Ratio | 0.99 | 0.17 | 582% |
Annual Report Gross Expense Ratio | 1.10 | 0.17 | 647% |
Fund Existence | 19 years | 33 years | - |
Gain YTD | 5.289 | 2.419 | 219% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 308M | 189B | 0% |
Annual Yield % from dividends | 1.26 | 2.16 | 59% |
Returns for 1 year | 5.44 | 8.01 | 68% |
Returns for 3 years | 18.01 | 32.20 | 56% |
Returns for 5 years | 36.72 | 72.56 | 51% |
Returns for 10 years | 19.38 | 103.54 | 19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WCEIX | 10.98 | -0.04 | -0.36% |
Virtus Westchester Event-Driven Fd I | |||
FSMEX | 58.64 | -0.47 | -0.80% |
Fidelity Select Medical Tech and Devcs | |||
JGSRX | 12.73 | -0.14 | -1.09% |
JHancock Global Shareholder Yield R2 | |||
MSCUX | 11.89 | -0.15 | -1.25% |
Morgan Stanley American Resilience A | |||
CMJAX | 40.97 | -0.62 | -1.49% |
Calvert US Mid Cap Core Rspnb Idx A |